Noerr advised Laureus Capital GmbH on the deal. Laureus is acquiring an interest in Munich-based biotechnology company Ethris as part of a Series B funding round...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here